Clinical Trials Directory

Trials / Completed

CompletedNCT02745522

Can Oxytocin Enhance the Placebo Effect?

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
224 (actual)
Sponsor
University of Electronic Science and Technology of China · Academic / Other
Sex
Male
Age
18 Years – 30 Years
Healthy volunteers
Accepted

Summary

The current study aimed to investigate whether oxytocin (OXT) had effect on placebo effect.

Detailed description

The current study included three phases to investigate oxytocin effect on placebo effect: 1. In a double-blind, between-subject, placebo controlled design study to investigate the intranasal OXT (24IU) treatment in 66 healthy male subjects using working memory task. 2. In a single-blind(subjects were informed that the treatment was oxytocin), between-subject, placebo controlled design study to investigate the intranasal OXT (24IU) treatment in 53 healthy male subjects using working memory task.They were informed that oxytocin would increase memory perfomance by a female experimenter. 3. In a single-blind(subjects were informed that the treatment was oxytocin), between-subject, placebo controlled design study to investigate the intranasal OXT (24IU) treatment in 53 healthy male subjects using working memory task. But the subjects were told that oxytocin would decrease the performance by the same female experimenter. 4. In a single-blind(subjects were informed that the treatment was oxytocin), between-subject, placebo controlled design study to investigate the intranasal OXT (24IU) treatment in 52 healthy male subjects using working memory task. The subjects were told that oxytocin would increase the performance by a male experimenter. Memory performance was included as dependant factor. All subjects completed a range of questionnaires measuring personality and affective traits and levels of anxiety: State-Trait Anxiety Inventory (STAI), Beck Depression Inventory (BDI), Interpersonal Trust Scale(ITS).

Conditions

Interventions

TypeNameDescription
DRUGOxytocin
DRUGPlacebo

Timeline

Start date
2015-12-01
Primary completion
2017-03-01
Completion
2017-08-01
First posted
2016-04-20
Last updated
2018-10-15

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02745522. Inclusion in this directory is not an endorsement.